Your browser doesn't support javascript.
loading
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Minami, Keita; Osawa, Takahiro; Kojima, Takahiro; Hara, Tomohiko; Eto, Masatoshi; Takeuchi, Ario; Nakai, Yasutomo; Ueda, Kosuke; Ozawa, Michinobu; Uemura, Motohide; Ohba, Kojiro; Tamura, Keita; Shindo, Tetsuya; Nakagomi, Hiroshi; Takahashi, Atsushi; Anai, Satoshi; Yokomizo, Akira; Morizane, Shuichi; Kimura, Takahiro; Shimazui, Toru; Miyauchi, Yasuyuki; Mitsuzuka, Koji; Hara, Hiroaki; Yoshimura, Koji; Shiina, Hiroaki; Ito, Youichi M; Murai, Sachiyo; Nishiyama, Hiroyuki; Shinohara, Nobuo; Kitamura, Hiroshi.
Afiliação
  • Minami K; Department of Urology, Sapporo City General Hospital, Sapporo, Japan.
  • Osawa T; Department of Urology, Hokkaido University Hospital, Sapporo, Japan. Electronic address: taka0573@gmail.com.
  • Kojima T; Department of Urology, Aichi Cancer Center, Aichi, Japan.
  • Hara T; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Eto M; Department of Urology, Kyushu University, Fukuoka, Japan.
  • Takeuchi A; Department of Urology, Kyushu University, Fukuoka, Japan.
  • Nakai Y; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Ueda K; Department of Urology, Kurume University Hospital, Kurume, Japan.
  • Ozawa M; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Uemura M; Department of Urology, Osaka University Hospital, Suita, Japan.
  • Ohba K; Department of Urology, Nagasaki University Hospital, Nagasaki, Japan.
  • Tamura K; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Shindo T; Department of Urology, Sapporo Medical University, Sapporo, Japan.
  • Nakagomi H; Department of Urology, University of Yamanashi Hospital, Chuo, Japan.
  • Takahashi A; Department of Urology, Hakodate Goryoukaku Hospital, Hakodate, Japan.
  • Anai S; Department of Urology, Nara Medical University, Kashihara, Japan.
  • Yokomizo A; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
  • Morizane S; Department of Urology, Tottori University, Yonago, Japan.
  • Kimura T; Department of Urology, The Jikei University, School of Medicine, Tokyo, Japan.
  • Shimazui T; Department of Urology, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Japan.
  • Miyauchi Y; Department of Urology, Kagawa University, Takamatsu, Japan.
  • Mitsuzuka K; Department of Urology, Tohoku University, Sendai, Japan.
  • Hara H; Department of Urology, Shinshu University Hospital, Matsumoto, Japan.
  • Yoshimura K; Department of Urology, Shizuoka General Hospital, Shizuoka, Japan.
  • Shiina H; Department of Urology, Shimane University, Izumo, Japan.
  • Ito YM; Data Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo, Japan.
  • Murai S; Department of Urology, Hokkaido University Hospital, Sapporo, Japan.
  • Nishiyama H; Department of Urology, University of Tsukuba Hospital, Tsukuba, Japan.
  • Shinohara N; Department of Urology, Hokkaido University Hospital, Sapporo, Japan.
  • Kitamura H; Department of Urology, Toyama University Hospital, Toyama, Japan.
Urol Oncol ; 41(11): 458.e9-458.e19, 2023 11.
Article em En | MEDLINE | ID: mdl-37798145
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article